SCHEMBL2384584

SCHEMBL2384584

CN(C)Cc1cc(-c2cc(N3CCN(C)CC3)ccn2)cs1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH4 Q9H3N8 6/20 0.60
GLA P06280 2/20 0.40
MEN1 O00255 1/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 1/20 0.40
CXCR4 P61073 1/20 0.39
PIM1 P11309 1/20 0.39
PIM3 Q86V86 1/20 0.39
PIM2 Q9P1W9 1/20 0.39
MAP4K1 Q92918 1/20 0.37
ALDH1A1 P00352 2/20 0.37
CYP1A2 P05177 2/20 0.37
HSD17B10 Q99714 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
ALOX15 P16050 1/20 0.37
IKBKB O14920 1/20 0.37
CHUK O15111 1/20 0.37
KDM1A O60341 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2383248 0.88 HRH4 (0.63) HRH4GLAMEN1GAAKMT2A
SCHEMBL2382872 0.87 HRH4 (0.62) HRH4GLAMEN1GAAKMT2A
SCHEMBL2384680 0.79 HRH4 (0.64) HRH4GLAMEN1GAAKMT2A
SCHEMBL12257973 0.79 HRH4 (0.51) HRH4GLAMEN1GAAKMT2A
SCHEMBL2385516 0.78 HRH4 (0.63) HRH4GLAMEN1GAAKMT2A
SCHEMBL2383589 0.76 HRH4 (0.60) HRH4GLAMEN1GAAKMT2A
SCHEMBL2384348 0.76 HRH4 (1.00) HRH4GLAMEN1GAAKMT2A
SCHEMBL2384160 0.74 HRH4 (0.68) HRH4GLAMEN1GAAKMT2A
SCHEMBL2385322 0.73 CYP1A2 (0.65) HRH4GLAMEN1GAAKMT2A
SCHEMBL2385040 0.72 HRH4 (0.66) HRH4GLAMEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022209-B2 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor JANSSEN PHARMACEUTICA NV (BE) 2011-09-20 US disclosed
WO-2009035671-A1 SUBSTITUTED NITROGEN-CONTAINING HETEROARYL DERIVATIVES USEFUL AS MODULATORS OF THE HISTAMINE H4 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2009-03-19 WO disclosed
US-20090069305-A1 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor JANSSEN PHARMACEUTICA N.V. (BE) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069305-A1 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor HRH4, HRH3, HRH2 HRH4 1/4885GLA 4816/4885MEN1 1954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.